Target intelligence / Profile preview

IκB kinase complex and Nuclear factor kappa B (NF-κB) pathway components (IKK/NF-κB)

Target
IKK/NF-κB
Molecular classification
Enzyme, Transcription factor, Protein complex
01

Overview

The IκB kinase (IKK) complex and the Nuclear factor kappa B (NF-κB) pathway components represent a fundamental signaling network that regulates the cellular response to inflammation, stress, and infection (Source: StatPearls, NBK557533). The IKK complex, primarily composed of the catalytic subunits IKKα (CHUK) and IKKβ (IKBKB) and the regulatory subunit NEMO (IKKγ), serves as the primary activator of the pathway by phosphorylating IκB inhibitory proteins (Source: UniProt, O14920). This phosphorylation triggers the ubiquitination and proteasomal degradation of IκB, thereby releasing NF-κB transcription factor dimers (such as p50/p65) to translocate from the cytoplasm to the nucleus (Source: PubMed, PMID: 11861295). Once in the nucleus, NF-κB binds to specific DNA sequences to induce the expression of genes involved in the innate and adaptive immune response, cell survival, and the production of pro-inflammatory cytokines like TNF-α and IL-6 (Source: PubMed, PMID: 15123778). Dysregulation of this pathway, particularly constitutive activation, is a hallmark of many human pathologies, including chronic inflammatory diseases (e.g., rheumatoid arthritis, IBD) and various malignancies where it promotes tumor cell proliferation and resistance to apoptosis (Source: Nature Reviews Drug Discovery, nrd1926). Therapeutic targeting of this pathway includes the use of proteasome inhibitors to prevent IκB degradation and direct IKK inhibitors, although the essential role of NF-κB in normal physiology often leads to significant safety concerns such as severe immunosuppression and toxicity (Source: PubMed, PMID: 24333740).

Other names
IKK complexNF-kappa-BI-kappa-B kinaseREL proteinsNFKBNuclear factor of kappa light polypeptide gene enhancer in B-cells
02

Mechanism of action

Inhibition of IκB kinase (IKK) activity, proteasomal inhibition preventing IκB degradation, blockade of NF-κB nuclear translocation, and inhibition of upstream pathway activators (Source: PubMed PMID: 16397573).

03

Biological functions

Immune responseInflammationCell survivalApoptosisCell proliferation
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionNeurodegenerative disease
05

Safety considerations

Immunosuppression (Source: Nature Reviews Drug Discovery)Increased risk of opportunistic infections (Source: Nature Reviews Drug Discovery)Hepatotoxicity (Source: PubMed PMID: 24333740)Gastrointestinal toxicity (Source: PubMed PMID: 24333740)Impaired wound healing (Source: PubMed PMID: 16397573)
06

Interacting drugs

Bortezomib

9 more in the full profile.

07

Biomarkers

Phosphorylated IκBα (Source: PubMed PMID: 11861295)Nuclear p65 (RelA) levels (Source: PubMed PMID: 15123778)Interleukin-6 (IL-6) (Source: StatPearls)Tumor necrosis factor-alpha (TNF-α) (Source: StatPearls)C-reactive protein (CRP) (Source: StatPearls)

Beyond the preview

Go deeper on IκB kinase complex and Nuclear factor kappa B (NF-κB) pathway components (IKK/NF-κB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IκB kinase complex and Nuclear factor kappa B (NF-κB) pathway components (IKK/NF-κB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call